Amygdala pharmacology and crime behavior, dysfunctions to be considered as a disease?

Simple item page
dc.contributor.authorLuisetto, M.en_US
dc.contributor.authorKhan, Farhan Ahmaden_US
dc.contributor.authorCabianca, Lucaen_US
dc.contributor.authorMokbul, Mobin Ibneen_US
dc.contributor.authorRafa, Ahmed Yesvien_US
dc.contributor.authorAhmadabadi, Behzad Nilien_US
dc.date.accessioned2019-11-16T07:23:15Z
dc.date.available2019-11-16T07:23:15Z
dc.date.issued2016-04
dc.description.abstractWe don’t have today drugs specifically registered for amygdala dysfunctions as preventable agents towards some kind of crime behavior. This Neuro psychiatric condition or organ state are to be considered and treated in preventive way as common disease. There is an amygdala physio-pathological Level of activation.  Still we are not sure to call this dysfunctions status as disease and drugs are needed or efficacy to control it. A neuro-pharmacology research of amygdala can give the response also using imaging Techniques. Studies demonstrated that Amygdala activation is involved in aggressive behavior. The aim of this work is to investigate in this relationship and to find if there is a level of activation.en_US
dc.identifier.affiliationsApplied Pharmacologist and European Specialist in Laboratory Medicine, Italyen_US
dc.identifier.affiliationsDepartment of Pharmacology, Teerthanker Mahaveer Medical College and Research Centre, TMU, India,en_US
dc.identifier.affiliationsBiomedical Laboratory, Italyen_US
dc.identifier.affiliationsFounder & President, International Light of Neuroscience Foundation House: 32/A, Road-03, Prianka Housing, Turag City, Mirpur-1, Dhaka-1216en_US
dc.identifier.affiliationsCo-Founder & General Secretary, ILNF Independent Neuroscience Researcher, Independent Applied Physics Researcher, Dhaka, Bangladeshen_US
dc.identifier.affiliationsNano Drug Delivery, Chapel Hill NC 27514, USAen_US
dc.identifier.citationLuisetto M., Khan Farhan Ahmad, Cabianca Luca, Mokbul Mobin Ibne, Rafa Ahmed Yesvi, Ahmadabadi Behzad Nili. Amygdala pharmacology and crime behavior, dysfunctions to be considered as a disease?. International Archives of BioMedical and Clinical Research. 2016 Apr-Jun; 2(2): 1-4en_US
dc.identifier.issn2454-9894
dc.identifier.issn2454-9886
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/184074
dc.languageenen_US
dc.publisherIbn Sina Academy of Medieval Medicine & Sciencesen_US
dc.relation.issuenumber2en_US
dc.relation.volume2en_US
dc.source.urihttps://doi.org/10.21276/iabcr.2016.2.2.1en_US
dc.subjectAmygdala activation levelen_US
dc.subjectPharmacology Neuro Imagingen_US
dc.subjectAntisocial personality disorderen_US
dc.titleAmygdala pharmacology and crime behavior, dysfunctions to be considered as a disease?en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
iabcr2016v2n2p1.pdf
Size:
453.66 KB
Format:
Adobe Portable Document Format
Download
Collections
International Archives of BioMedical and Clinical Research